scispace - formally typeset
D

David Mayerhoff

Researcher at Long Island Jewish Medical Center

Publications -  38
Citations -  3883

David Mayerhoff is an academic researcher from Long Island Jewish Medical Center. The author has contributed to research in topics: Schizophrenia & First episode. The author has an hindex of 16, co-authored 38 publications receiving 3794 citations. Previous affiliations of David Mayerhoff include University of Medicine and Dentistry of New Jersey & Albert Einstein College of Medicine.

Papers
More filters
Journal ArticleDOI

Duration of psychosis and outcome in first-episode schizophrenia.

TL;DR: Duration of psychosis before treatment may be an important predictor of outcome in first-episode schizophrenia, and is significantly associated with time to remission as well as with level of remission.
Journal ArticleDOI

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients

TL;DR: The female schizophrenic patients had a later onset and better treatment response than the men and the greater pharmacologic responsivity of the female patients is consistent with the gender difference in degree of symptom improvement with medication.
Journal ArticleDOI

Depression in first-episode schizophrenia.

TL;DR: These findings suggest that depressive symptoms in patients experiencing their first episode of schizophrenia may represent a core part of the acute illness or may occur as a subjective reaction to the experience of psychotic decompensation.
Journal ArticleDOI

Intellectual Deficits in First-Episode Schizophrenia: Evidence for Progressive Deterioration

TL;DR: The hypothesis that patients differ in the course of cognitive decline is supported and deterioration of function may follow the onset of overt psychosis in some patients is suggested; Prospective longitudinal studies of first-episode schizophrenic patients could directly test this hypothesis.